Steffen Zopf

2.1k total citations · 1 hit paper
45 papers, 1.0k citations indexed

About

Steffen Zopf is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Steffen Zopf has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 16 papers in Hepatology and 15 papers in Molecular Biology. Recurrent topics in Steffen Zopf's work include Liver Disease Diagnosis and Treatment (15 papers), Histone Deacetylase Inhibitors Research (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Steffen Zopf is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Histone Deacetylase Inhibitors Research (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Steffen Zopf collaborates with scholars based in Germany, Austria and United States. Steffen Zopf's co-authors include Markus F. Neurath, Matthias Ocker, Stefan Pflanz, David Voehringer, Marcus Schuchmann, Tamar Mchedlidze, Andrew L. Rankin, Stefan Wirtz, Jennifer A. Walker and Maximilian J. Waldner and has published in prestigious journals such as Immunity, Gastroenterology and PLoS ONE.

In The Last Decade

Steffen Zopf

45 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis

2013 418 citations Tamar Mchedlidze, Maximilian J. Waldner et al. Immunity profile →

Peers

Steffen Zopf

IMMUN

SURGE

EPIDE

HEPAT

H. P. Dienes Germany

Janeth C. Villanueva United States

Sabino Russi Italy

Janine Fear United Kingdom

Won‐Tak Choi United States

Junko Yokokawa Japan

Yoshiaki Ikuta Japan

Ping-I Hsu Taiwan

Alaa Melhem Israel

Hiroyuki Komori Japan

H. P. Dienes Germany

Steffen Zopf

210 ×0.6

IMMUN

300 ×1.0

SURGE

334 ×1.1

481 ×2.0

EPIDE

592 ×2.7

HEPAT

Citations per year, relative to Steffen Zopf Steffen Zopf (= 1×) peers H. P. Dienes

Countries citing papers authored by Steffen Zopf

Since Specialization

Citations

This map shows the geographic impact of Steffen Zopf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Zopf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Zopf more than expected).

Fields of papers citing papers by Steffen Zopf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Zopf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Zopf. The network helps show where Steffen Zopf may publish in the future.

Co-authorship network of co-authors of Steffen Zopf

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Zopf. A scholar is included among the top collaborators of Steffen Zopf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Zopf. Steffen Zopf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vetter, Marcel, Andreas E. Kremer, Abbas Agaimy, et al.. (2020). How Much Liver Tissue Is Required for Sufficient Histological Staging in Patients with Primary Biliary Cholangitis?. Digestion. 102(3). 428–436. 1 indexed citations

Räth, Timo, Lukáš Pfeifer, Clemens Neufert, et al.. (2020). Retrograde inspection vs standard forward view for the detection of colorectal adenomas during colonoscopy: A back-to-back randomized clinical trial. World Journal of Gastroenterology. 26(16). 1962–1970. 5 indexed citations

Vitali, Francesco, Andreas Naegel, Raja Atreya, et al.. (2019). Comparison of Hemospray^® and Endoclot^™ for the treatment of gastrointestinal bleeding. World Journal of Gastroenterology. 25(13). 1592–1602. 35 indexed citations

Zopf, Steffen, Clemens Neufert, Andreas Nägel, et al.. (2018). I-scan optical enhancement for the in vivo prediction of diminutive colorectal polyp histology: Results from a prospective three-phased multicentre trial. PLoS ONE. 13(5). e0197520–e0197520. 16 indexed citations

Schellhaas, Barbara, Deike Strobel, Marion Ganslmayer, et al.. (2018). Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts. European Journal of Gastroenterology & Hepatology. 30(12). 1422–1427. 3 indexed citations

Zopf, Steffen. (2016). Advances in hepatitis C therapy: What is the current state - what come's next?. World Journal of Hepatology. 8(3). 139–139. 41 indexed citations

Räth, Timo, Gian Eugenio Tontini, Andreas Nägel, et al.. (2015). High-definition endoscopy with digital chromoendoscopy for histologic prediction of distal colorectal polyps. BMC Gastroenterology. 15(1). 145–145. 8 indexed citations

Ganslmayer, Marion, Alexander Hagel, Wolfgang Dauth, et al.. (2014). A large cohort of patients with hepatocellular carcinoma in a single European centre: aetiology and prognosis now and in a historical cohort. Swiss Medical Weekly. 144(304). w13900–w13900. 10 indexed citations

Mchedlidze, Tamar, Maximilian J. Waldner, Steffen Zopf, et al.. (2013). Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis. Immunity. 39(2). 357–371. 418 indexed citations breakdown →

10.

Perrakis, Aristotelis, Roland S. Croner, Nikolaos Vassos, et al.. (2013). Liver Transplantation for Hepatitis B-Induced Liver Disease: Long-Term Outcome and Effectiveness of Antiviral Therapy for Prevention of Recurrent Hepatitis B Infection. Transplantation Proceedings. 45(5). 1953–1956. 4 indexed citations

11.

Goertz, Ruediger S., J. Sturm, Steffen Zopf, et al.. (2013). Outcome analysis of liver stiffness by ARFI (acoustic radiation force impulse) elastometry in patients with chronic viral hepatitis B and C. Clinical Radiology. 69(3). 275–279. 13 indexed citations

12.

Zopf, Steffen, Matthias Ocker, Daniel Neureiter, et al.. (2012). Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines. BMC Cancer. 12(1). 386–386. 37 indexed citations

13.

Ganslmayer, Marion, Peter C. Konturek, C. Herold, Markus F. Neurath, & Steffen Zopf. (2012). Antitumoral efficacy of four histone deacetylase inhibitors in hepatoma in vitro and in vivo.. PubMed. 32(12). 5263–9. 6 indexed citations

14.

Okamoto, Kinya, Matthias Ocker, Daniel Neureiter, et al.. (2007). bcl‐2‐specific siRNAs restore Gemcitabine sensitivity in human pancreatic cancer cells. Journal of Cellular and Molecular Medicine. 11(2). 349–361. 29 indexed citations

15.

Gahr, Susanne, Matthias Ocker, Marion Ganslmayer, et al.. (2007). The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. International Journal of Oncology. 31(3). 567–76. 26 indexed citations

16.

Neureiter, Daniel, Steffen Zopf, Otto Dietze, et al.. (2006). Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models. Scandinavian Journal of Gastroenterology. 42(1). 103–116. 61 indexed citations

17.

Ocker, Matthias, Abdullah Alajati, Marion Ganslmayer, et al.. (2005). The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells. Journal of Cancer Research and Clinical Oncology. 131(6). 385–394. 58 indexed citations

18.

Ocker, Matthias, et al.. (2004). Potentiated anticancer effects on hepatoma cells by the retinoid adapalene. Cancer Letters. 208(1). 51–58. 19 indexed citations

19.

Fiedler, Martin, et al.. (2003). Human renal fibroblasts derived from normal and fibrotic kidneys show differences in increase of extracellular matrix synthesis and cell proliferation upon angiotensin II exposure. Pflügers Archiv - European Journal of Physiology. 446(3). 387–393. 23 indexed citations

20.

Herold, C., Marion Ganslmayer, Matthias Ocker, et al.. (2003). Inducibility of microsomal liver function may differentiate cirrhotic patients with maintained compared with severely compromised liver reserve. Journal of Gastroenterology and Hepatology. 18(4). 445–449. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact